Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|February 21, 2024
Janus kinase inhibition in the treatment and prevention of graft-versus-host diseaseElisa De Togni, Oladipo Cole, Ramzi Abboud
Leukemia & Lymphoma|July 18, 2022
The impact of tocilizumab treatment for cytokine release syndrome on the incidence of early blood stream infections after peripheral blood haploidentical hematopoietic cell transplantationElisa De Togni, Fei Wan, Michael Slade, et al.
Bone Marrow Transplantation|April 28, 2023
Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantationAaron Pruitt, Feng Gao, Elisa De Togni, et al.
Bone Marrow Transplantation|July 15, 2021
Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysisRamzi Abboud, Fei Wan, Jacopo Mariotti, et al.
Therapeutic Advances in Hematology|June 16, 2020
Insights into the role of the JAK/STAT signaling pathway in graft-<i>versus</i>-host diseaseRamzi Abboud, Jaebok Choi, Peter Ruminski, et al.
Leukemia & Lymphoma|November 19, 2021
Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamideLuke Eastburg, David A Russler-Germain, John F DiPersio, et al.
Research Square|January 23, 2024
Pretransplant Desensitization of Donor-Specific Anti-HLA Antibodies with Plasmapheresis and Immunoglobulin Produces Equivalent Outcomes to Patients with No Donor Specific Antibodies in Haploidentical Hematopoietic Cell TransplantHunter Cochran, Michael Slade, Feng Gao, et al.
Leukemia & Lymphoma|July 11, 2024
Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodies in haploidentical hematopoietic cell transplantHunter Cassidy Cochran, Michael Joseph Slade, Chang Liu, et al.
Blood|February 29, 2008
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression dataDuane C Hassane, Monica L Guzman, Cheryl Corbett, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 30, 2020
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective studyNahid Rashid, Michael Slade, Ramzi Abboud, et al.
Pageof 2